The first scalable biological screening test for dementia. We want to increase people's quality of life by reducing the time-to-treatment and facilitating access to support programs for people with a high risk for dementia.

Problem: Medical dementia workups are expensive and invasive, therefore having a screening tool to determine whether such procedures are worthwhile is of great benefit to patients and physicians.

Solution: BrainTrip has developed an algorithm that is paired with an off-the-shelf electroencephalogram (EEG) and used as a risk-assessment tool for dementia. It is suitable for people over 60, when the chances of dementia start increasing rapidly. Our goal is to determine who is at higher risk for dementia and is thus in most need of treatment and support. The test can be applied in a matter of minutes and is completely non-invasive: no needles, chemicals, or radiation exposure. After the test, the client is told that their results show no cognitive impairment, or, if this is not the case, they received personalized advice.

Team: Startup with two Slovenian founders, incubated at Rockstart Health. The team is very diverse, having experience in EEG-data analysis, neuroscience, software development, and team management.

Plans: We are currently planning our first pilot with Sensire, an elder-care organization in the Netherlands, to launch the pilot with them in Q2 2020.


Bedrijfsnaam: BrainTrip
Organisatietype: Bedrijf
Specialisatie: Biotechnologie, Gezondheid & Welzijn, ICT
Bezoekadres: Transistorweg 7, 6534 AT, Nijmegen, Nederland
Postadres: Transistorweg 7s, 6534 AT, Nijmegen, Nederland
KvK: 00000001


Making the difference by unlocking new value

Is dit bedrijf voor jou een potentiële match? Neem dan contact op met:

Koen van den Hurk
Innovatiemanager Health Valley Netherlands

Koen van den Hurk

Health Valley Partners